Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects (Q43989951)

28 November 2017

title

Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects (English)

1 reference

28 November 2017

0 references

0 references

10

Ralph A DeFronzo

1 reference

28 November 2017

7

Lawrence Mandarino

1 reference

28 November 2017

author name string

Thongchai Pratipanawatr

1

1 reference

28 November 2017

Wilailak Pratipanawatr

2

1 reference

28 November 2017

Clifford Rosen

3

1 reference

28 November 2017

Rachele Berria

4

1 reference

28 November 2017

Mandeep Bajaj

5

1 reference

28 November 2017

Kenneth Cusi

6

1 reference

28 November 2017

Sangeta Kashyap

8

1 reference

28 November 2017

Renata Belfort

9

1 reference

28 November 2017

publication date

1 June 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

28 November 2017

published in

1 reference

28 November 2017

volume

282

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

E1360-8

1 reference

Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Effects of recombinant human IGF-I on glucose and leucine kinetics in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Effect of insulin on the distribution and disposition of glucose in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Parallel insulin-like growth factor I and insulin resistance in muscles of rats fed a high fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Metabolic effects of IGF-I in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Indirect calorimetry: methodological and interpretative problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Insulin-like growth factor I receptors in adult rat liver: characterization and in vivo regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00335.2001

10.1152/AJPENDO.00335.2001

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference